source
- Eli Lilly reports strongest weight-loss data yet; Sanofi and Regeneron secure $1 billion upfront dealThe weekly Endpoints newsletter dated October 3, 2026 highlights that Eli Lilly's latest weight‑loss trial produced its best‑ever results. While the article does not provide specific numbers, the…
- Novartis signs $7.8 billion deal with Abogen for mRNA-encoded autoimmune T-cell engagerNovartis announced it will pay $575 million upfront to Abogen Biosciences for an mRNA-encoded T-cell engager that has shown early clinical activity in autoimmune disease. The agreement includes up…